$1.20
47.51% yesterday
Nasdaq, Jun 11, 10:17 pm CET
ISIN
US63008J1088
Symbol
NAOV

NanoVibronix, Inc. Stock price

$1.20
-2.91 70.80% 1M
-5.40 81.82% 6M
-5.29 81.51% YTD
-7.66 86.45% 1Y
-524.58 99.77% 5Y
-878.80 99.86% 10Y
-768.80 99.84% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
+0.39 47.51%
ISIN
US63008J1088
Symbol
NAOV
Sector

Key metrics

Market capitalization $3.10m
Enterprise Value $6.25m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.35
P/S ratio (TTM) P/S ratio 1.17
P/B ratio (TTM) P/B ratio 0.02
Revenue growth (TTM) Revenue growth -6.67%
Revenue (TTM) Revenue $2.66m
EBIT (operating result TTM) EBIT $-4.87m
Free Cash Flow (TTM) Free Cash Flow $-3.29m
Cash position $600.00k
EPS (TTM) EPS $-8.96
Short interest 43.27%
Show more

Is NanoVibronix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,840 stocks worldwide.

NanoVibronix, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

Buy
100%

Financial data from NanoVibronix, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2.66 2.66
7% 7%
100%
- Direct Costs 1.45 1.45
63% 63%
55%
1.21 1.21
39% 39%
45%
- Selling and Administrative Expenses 4.76 4.76
2% 2%
179%
- Research and Development Expense 1.32 1.32
428% 428%
50%
-4.85 -4.85
64% 64%
-182%
- Depreciation and Amortization 0.02 0.02
-
1%
EBIT (Operating Income) EBIT -4.87 -4.87
65% 65%
-183%
Net Profit -5.61 -5.61
75% 75%
-211%

In millions USD.

Don't miss a Thing! We will send you all news about NanoVibronix, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NanoVibronix, Inc. Stock News

Neutral
Business Wire
about 22 hours ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ENvue Medical Holdings LLC division (“ENvue Medical” or “ENvue”), a new U.S. patent for its pediatric feeding tube guidance system. U.S. Patent No. 12,324,632, titled “Insertion Device Positioning Guida...
Neutral
Business Wire
8 days ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the retirement of Brian Murphy as Chief Executive Officer, effective immediately. The Company's Board of Directors has appointed Doron Besser, CEO of ENvue Medical Holdings, LLC (“ENvue”), a wholly-owned subsidiary ...
Neutral
Business Wire
15 days ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) confirmed that a series of posts made earlier today with respect to a $26 million registered direct offering of common stock of the Company priced at $0.45 under Nasdaq rules was falsely issued by Flash Alert and FintelAlerts. The Company has not priced and is not consummating any registered direct offering. The Co...
More NanoVibronix, Inc. News

Company Profile

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.

Head office United States
CEO Brian Murphy
Employees 31
Founded 2003
Website nanovibronix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today